key: cord-0976902-uddwc4tu
authors: Tang, Alan T.; Buchholz, David W.; Szigety, Katherine M.; Imbhiaka, Brian; Gao, Siqi; Frankfurter, Maxwell; Wang, Min; Yang, Jisheng; Hewins, Peter; Mericko-Ishizuka, Patricia; Adrian Leu, N; Sterling, Stephanie; Monreal, Isaac A.; Sahler, Julie; August, Avery; Zhu, Xuming; Jurado, Kellie A.; Xu, Mingang; Morrisey, Edward E.; Millar, Sarah E.; Aguilar, Hector C.; Kahn, Mark L.
title: SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in mice
date: 2021-12-07
journal: bioRxiv
DOI: 10.1101/2021.12.04.471245
sha: 96d127f91d8cb0f7fcbdcba66bec8b9b5a06b507
doc_id: 976902
cord_uid: uddwc4tu

Lethal COVID-19 is associated with respiratory failure that is thought to be caused by acute respiratory distress syndrome (ARDS) secondary to pulmonary infection. To date, the cellular pathogenesis has been inferred from studies describing the expression of ACE2, a transmembrane protein required for SARS-CoV-2 infection, and detection of viral RNA or protein in infected humans, model animals, and cultured cells. To functionally test the cellular mechanisms of COVID-19, we generated hACE2fl animals in which human ACE2 (hACE2) is expressed from the mouse Ace2 locus in a manner that permits cell-specific, Cre-mediated loss of function. hACE2fl animals developed lethal weight loss and hypoxemia within 7 days of exposure to SARS-CoV-2 that was associated with pulmonary infiltrates, intravascular thrombosis and patchy viral infection of lung epithelial cells. Deletion of hACE2 in lung epithelial cells prevented viral infection of the lung, but not weight loss, hypoxemia or death. Inhalation of SARS-CoV-2 by hACE2fl animals resulted in early infection of sustentacular cells with subsequent infection of neurons in the neighboring olfactory bulb and cerebral cortex— events that did not require lung epithelial cell infection. Pharmacologic ablation of the olfactory epithelium or Foxg1Cre mediated deletion of hACE2 in olfactory epithelial cells and neurons prevented lethality and neuronal infection following SARS-CoV-2 infection. Conversely, transgenic expression of hACE2 specifically in olfactory epithelial cells and neurons in Foxg1Cre; LSL-hACE2 mice was sufficient to confer neuronal infection associated with respiratory failure and death. These studies establish mouse loss and gain of function genetic models with which to genetically dissect viral-host interactions and demonstrate that lethal disease due to respiratory failure may arise from extrapulmonary infection of the olfactory epithelium and brain. Future therapeutic efforts focused on preventing olfactory epithelial infection may be an effective means of protecting against severe COVID-19.

genetically dissect viral-host interactions and demonstrate that lethal disease due to respiratory 50 failure may arise from extrapulmonary infection of the olfactory epithelium and brain. Future 51

The application of mouse models to investigate COVID-19 pathogenesis has been 79 hindered by the fact that that the SARS-CoV-2 spike protein is unable to bind the mouse ACE2 80 protein, a necessary first step in viral cellular entry and infection 1,12 . Several human ACE2 81 (hACE2)-expressing mouse models have been generated to investigate COVID-19 82 pathogenesis 4,7,15,16 , but only the K18-hACE2 line confers severe illness like that observed in 83 patients 6 . K18-hACE2 random transgenic mice express hACE2 in a non-endogenous fashion that 84 is primarily restricted to epithelial cells, and do not enable genetic dissection of viral 85 pathogenesis. To identify cell specific roles during SARS-CoV-2 infection, we generated new 86 lines of mice in which hACE2 is expressed from the mouse Ace2 locus in a manner that enables To genetically investigate the cellular pathogenesis of COVID-19 disease in vivo, we 95 generated gene targeted mice in which the coding sequence of the first translated exon of the 96 mouse Ace2 gene (exon 2) was replaced by an expression cassette including the human ACE2 97 cDNA followed by a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) 98 and simian-virus 40 (SV40) late polyA sequence (Fig. 1a) . Since the start codon in Exon 2 is 99 preceded by inter-species conserved 5' untranslated sequence, we inserted loxP sites flanking the 100 WPRE-polyA sequence to enable Cre-mediated loss of ACE2 expression without altering 101 endogenous 5' regulation of the Ace2 locus. To compare hACE2 protein expression from the 102 gene targeted allele (hereafter termed "hACE2 fl ") and mouse ACE2 (mACE2) protein expression 103 from the endogenous Ace2 gene, we performed western blotting of whole tissue lysates from 104 tissues known to express ACE2. Male mice were used because the Ace2 allele is located on the 105 X chromosome, enabling a straightforward comparison from the single expressed allele in all cell 106 types of hACE2 fl/y animals. Western blotting with pan-ACE2 antibodies that recognize both 107 hACE2 and mACE2 proteins revealed similar levels of ACE2 expression in heart, intestine, 108 kidney and lung (Fig. 1b) . To test the ability of Cre-mediated loss of the floxed WPRE-polyA 109 cassette to block hACE2 protein expression, we generated germline, Cre-recombined animals 110 (hACE2 del/y ) through intercrosses with Sox2-Cre animals. Western blotting with human ACE2-111 specific antibodies comparing wildtype, hACE2 fl/y , and hACE2 del/y animals demonstrated loss of 112 hACE2 protein in whole kidney and intestine (ileum) lysates (Fig. 1c) . 113

To further compare expression and localization of hACE2 in knock-in animals and 114 endogenous mACE2 expression, we next performed immunostaining of tissue sections with pan-115 ACE2 antibodies and antibodies specific for hACE2. ACE2 expression was detected in a 116 discontinuous pattern on the apical brush border of ciliated epithelial cells in the anterior and 117 posterior nasal respiratory epithelium of both hACE2 fl and wild-type mice (Fig. 1d) , a finding 118 consistent with prior reports of its localization in ciliated epithelial cells 9,17 . Immunostaining of 119 epithelial cells in the olfactory epithelium, intestine and kidney using pan-ACE2 and human-120 specific ACE2 antibodies also showed similar expression levels and an apical cellular expression 121 pattern in control and hACE2 fl animals ( Fig. 1e-g) , while staining of the lung failed to reveal 122 detectable ACE2 expression in either wild-type or hACE2 fl mice (not shown). Lastly, 123

immunostaining of hACE2 del/y tissues demonstrated loss of hACE2 expression in the intestine 124

and kidney compared to littermate hACE2 fl/y tissues (Fig. 1h) . These studies suggested that the 125 hACE2 fl allele expresses hACE2 in a manner like that of the endogenous mouse Ace2 allele, and 126 that hACE2 protein expression is lost following Cre-mediated removal of the WPRE-polyA 127 cassette. 128 129 hACE2 fl mice experience lethal infection following exposure to SARS-CoV-2 130 A subset of human patients exposed to SARS-CoV-2 virus experience severe illness that 131 leads to rapid respiratory failure and death 18, 19 . This severe disease course has been reproduced 132 in K18-hACE2 transgenic mice that over-express hACE2 in epithelial cells throughout the 133 respiratory tract 6 , but not in other animal models such as hamsters or previously reported hACE2 134 knockin mice 5,7,15,20,21 . To define the disease response of hACE2 fl mice, we exposed hACE2 fl/y 135 and hACE2 del/y littermates to 10 5 PFU of SARS-CoV-2 virus via nasal inhalation (Fig. 2a) . 136 hACE2 fl/y animals exhibited weight loss beginning 2 days after viral exposure and appeared 137 lethargic, hunched and with ruffled fur by day 4, with sacrifice or death of all animals by 6 days 138 post-infection due to >20% weight loss (humane endpoint) and/or respiratory distress (marked by 139 tachypnea and flank heaving). In contrast, infected hACE2 del/y mice exhibited no weight loss or 140 respiratory distress at timepoints up to 14 days post-infection (Fig. 2b, c) , functionally 141 confirming the loss of hACE2 function with Cre-recombination. Similar findings were obtained 142 following exposure to 10 4 PFU of SARS-CoV-2 virus (Fig. 2d, e) , and following infection of 143 hACE2 fl/y animals in two distinct ABSL3 facilities (Ext. Data Fig. 1 ). In contrast to hACE2 fl/y 144 animals, a previously reported strain of hACE2 conditional knock-in animals 20 failed to exhibit 145 significant weight loss or lethality after exposure to 10 5 SARS-CoV-2 virus (Fig. 2f, g) . 146

Human studies have revealed a sex difference in COVID-19 susceptibility, with male sex 147 identified as an independent risk factor for severe illness and death 22,23 . Consistent with these 148 human findings, although severe weight loss and 100% mortality were observed in both groups 149 male animals exhibited symptoms at earlier timepoints than females (Fig. 2h, i) . Collectively, 150 these studies demonstrate that hACE2 fl/y animals develop reproducible, severe disease and 151 lethality after exposure to the SARS-CoV-2 virus. suggested that AT2 cell infection might play a key role in COVID-19 pneumonia 24-27 . Therefore, 160 we next used the Sftpc CreERT2 knock-in allele to test whether ACE2-dependent infection of AT2 161 cells is required for lung infection in hACE2 fl animals. Following tamoxifen induction to activate 162

Cre recombination, Sftpc CreERT2 ; hACE2 fl/y males infected with SARS-CoV-2 virus exhibited 163 levels of viral nucleocapsid protein and viral RNA in the lung that were indistinguishable from 164 hACE2 fl/y animals by IHC and qPCR (Fig. 3a, b) . These findings suggested that cell-types other 165 than AT2 cells support SARS-CoV-2 infection of the lung, with the caveat that failure to detect 166 hACE2 expression in AT2 cells precludes confirmation of its loss in those cells in Sftpc CreERT2 ; 167 hACE2 fl/y animals. inflammatory response 13,30 . The extent to which these two mechanisms of lung disease are inter-186 connected and their respective roles in COVID-19 mortality have been difficult to define. 187

Following exposure to 10 4 PFU per mouse of SARS-CoV-2, both hACE2 fl/y and Shh Cre ; 188 hACE2 fl/y animals exhibited weight loss and lethality (Fig. 4a, b) . There was a small delay in the 189 onset of symptoms in Shh Cre ; hACE2 fl/y animals, but both hACE2 fl/y and Shh Cre ; hACE2 fl/y animals 190 were severely hypoxic 5-6 days after infection, with oxygen (O2) saturations ranging between 70 191 and 85%, levels similar to those of severely ill patients requiring mechanical ventilation (Fig.  192 4c). H&E staining of lung sections from wildtype, hACE2 fl/y and Shh Cre ; hACE2 fl/y animals 6 193 days after exposure to SARS-CoV-2 revealed alveolar consolidation, interstitial thickening and 194 the presence of focal infiltrates and hemorrhage in both hACE2 fl/y and Shh Cre ; hACE2 fl/y animals 195 that were not observed in wildtype controls (Fig. 4d) . Virtually identical results were obtained 196 following exposure to 10 5 PFU of SARS-CoV-2 (Ext. Data Fig. 4 ). SARS-CoV-2 infected 197 hACE2 fl/y and Shh Cre ; hACE2 fl/y animals also exhibited thrombus-filled pulmonary vessels that 198

were not observed in the lungs of wild-type animals exposed to virus (Fig. 4d , e and Ext. Data 199 suggesting that these sites of high ACE2 expression may be responsible for the lethal response to 225

Therefore, we next compared SARS-CoV-2 nucleocapsid staining in the OE and adjacent 227 olfactory bulb (OB) of the brain during the course of infection in wild-type, hACE2 fl/y and Shh Cre ; 228 hACE2 fl/y animals. 2 days after infection, abundant SARS-CoV-2 nucleocapsid was observed in 229 the nasal respiratory and olfactory epithelium of hACE2 fl/y and Shh Cre ; hACE2 fl/y animals, but 230 none was detected in the adjacent OB and cerebral cortex of the brain (Fig. 5a, c) . In contrast, 5-231 6 days after infection relatively little SARS-CoV-2 nucleocapsid was detected in the RE and OE 232 of hACE2 fl/y and Shh Cre ; hACE2 fl/y animals, although abundant signal was then detected in the 233 neighboring OB, cerebral cortex, and hippocampus (Fig. 5b, d suggest that early infection of the OE is followed by later infection of neurons in both 246 neighboring and distal sites in the brain following SARS-CoV-2 exposure. 247 248

The ciliated epithelium of the choroid plexus expresses genes required for SARS-CoV-2 250 entry, and a recent study reported an anti-viral inflammatory response at that site in post-mortem 251 biopsies from 8 COVID-19 patients even though no virus could be detected in those samples 33,34 252 (discussed further below). Since our studies of the OE and OB suggested that neuronal infection 253 may be linked to adjacent epithelial cell infection, we next assessed the choroid plexus of 254 infected hACE2 mice. Unlike the OE, SARS-CoV-2 nucleocapsid was not detected in the 255 choroid plexus or adjacent neurons at an early timepoint, 2 days, after infection (Fig. 6a) . The studies described above, and prior studies of SARS-CoV-2 in the tissues of patients 270 who died of COVID-19 disease 36 , support a pathogenic mechanism in which SARS-CoV-2 virus 271 first infects the OE and subsequently spreads to the brain. Since OSNs are the primary cellular 272 connection between the brain and the ACE2-rich OE that is infected soon after exposure to 273 SARS-CoV-2 ( Fig. 5a) , we next assessed whether and when OSN infection might take place 274 following viral exposure. 2 days after infection with SARS-CoV-2 virus, hACE2 fl/y mice 275 exhibited viral RNA in the RE and OE (Fig. 7a ). Co-staining for the neuronal marker progressed to the OB and cerebral cortex, we detected β3-tubulin-labeled, immature OSNs in the 279 OE that co-stained with SARS-CoV-2 nucleocapsid (Fig. 7c) . These findings suggest a 280 mechanism in which infection of the OE and OSNs provides viral passage to neurons in the 281

To further investigate the mechanism of SARS-CoV-2 brain infection in hACE2 fl/y mice, 283

we compared the expression of ACE2 in wild-type and hACE2 fl/y mouse brains. Immunostaining 284 of brain sections and immunoblotting of brain cell lysate using pan-ACE2 antibodies that 285 recognize both mouse and human ACE2 protein revealed strong expression of ACE2 in 286 hACE2 fl/y brains (Fig 7d-f ). In contrast, ACE2 could not be detected using either method in wild-287 type mouse brain ( Fig. 7d-f ) and was detected at lower levels in human brain cell lysate (Fig. 7e) . 288

These results suggested that hACE2 fl/y mice express levels of ACE2 in the brain higher than those 289 in wild-type mice and humans, raising the possibility that brain infection may be a consequence 290 of elevated levels of brain ACE2 in that model and not accurately reflect infection in the wild-291 type mouse or human brain. 292

To address this possibility, we generated a second line of ATG-knock in animals: 293 hACE2-GFP fl mice, in which the hACE2 protein is fused to monomeric Emerald (mEmerald, a 294 green fluorescent protein (GFP) mutated to prevent auto-dimerization and improve solubility) 295 using the same conditional strategy previously described for hACE2 fl mice (Fig. 7g) . 296

Immunoblotting of kidney cell lysate and immunostaining of small intestine tissue sections 297 demonstrated appropriate expression of the hACE2-GFP protein in ciliated epithelial cells in 298 vivo (Ext. Data Fig. 7) . In contrast to hACE2 fl/y brains, but like those of wild-type mice and 299 healthy humans, hACE2-GFP fl/y brains expressed undetectable levels of hACE2 protein using 300 immunoblotting of brain cell lysate (Fig. 7h ). To test whether brain infection by SARS-CoV-2 301 was merely a consequence of high brain ACE2 expression in hACE2 fl/y mice, we next infected 302 hACE2-GFP fl/y mice with SARS-CoV-2 virus. hACE2-GFP fl/y mice exhibited weight loss 4 days 303 after infection and lethality by day 6 (Fig. 7i, j) . Significantly, analysis of the cerebral cortex 6 304 days after infection revealed SARS-CoV-2 nucleocapsid in NeuN-positive neurons and reactive 305 gliosis of hACE2-GFP fl/y animals (Fig. 7k) , consistent with neuronal infection like that observed 306 in hACE2 fl/y mice. H&E staining also revealed meningeal and peri-vascular inflammatory 307 infiltrates ( Fig. 7l) , as well as patchy peri-meningeal sites of neuronal nucleocapsid staining like 308 those seen in hACE2 fl/y mice (Ext. Data Fig. 8 ). These studies confirm that neuronal infection 309 takes place in animals that express levels of hACE2 in the brain like those in the wild-type 310 mouse and human brain and provide additional evidence for a pathogenic link between infection 311 of the OE, OSN and brain during lethal COVID-19. The studies described above indicated that SARS-CoV-2 infection of the OE rather than 316 the lung is associated with weight loss and lethality. Since genetic tools to drive Cre expression 317 selectively in the OE are not available, we tested the requirement for OE infection using 318 pharmacologic ablation of olfactory epithelial cells with methimazole (MMZ), a compound that 319 is highly and specifically toxic for the OE in rodents 37 . H&E staining of the OE 24 hours after 320 treatment of hACE2 fl/y mice with 100 mg/kg methimazole revealed loss of almost all olfactory 321 epithelial cells (Fig. 8a) . In contrast, the underlying olfactory bulb and lung did not show 322 evidence of cell loss, damage, or inflammation (Fig. 8a) . We next tested whether ablation of the 323 OE with MMZ impacts the clinical course of hACE2 fl/y mice infected with SARS-CoV-2 virus. 324

Remarkably, pre-treatment with MMZ 24 hours prior to intranasal inoculation of SARS-CoV-2 325 prevented both weight loss and death in the majority of hACE2 fl/Y mice (Fig. 8b, c) . 326

Immunostaining of the brain for SARS-CoV-2 nucleocapsid protein at 6 days after infection 327 revealed the absence of detectable virus in the cerebral cortex of MMZ-treated hACE2 fl/y mice 6 328 days after infection compared with vehicle-treated controls (Fig. 8d) . In contrast, similar 329 expression of SARS-CoV-2 nucleocapsid was detected in the lungs of vehicle-treated and MMZ-330 treated hACE2 fl/y mice (Fig. 8e) . Analysis of MMZ-treated hACE2 fl/y mice 14 days after SARS-331

CoV-2 infection revealed no viral nucleocapsid in either the brain or lung (Fig. 8f, g) , consistent 332 with sparing of the brain and resolution of lung infection in surviving MMZ-treated hACE2 fl/y 333 mice. Consistent with brain infection being a driver of lethality, analysis of a single hACE2 fl/y 334 mouse that became ill and was euthanized 8 days after infection revealed strong staining for 335 nucleocapsid in the brain and lung (Ext. Data Fig. 9) . 336

To further test the requirement for SARS-CoV-2 infection of the OE and brain for lethal 337 COVID-19 in hACE2 fl/y mice, we generated Foxg1 Cre/+ ; hACE2 fl/y mice in which Cre 338 recombinase is expressed in the OE and neurons of the forebrain, but not in cells of the lung 38 339 (Fig. 8h) . Following exposure to SARS-CoV-2, hACE2 fl/y littermate mice exhibited weight loss 340 and lethality associated with severe hypoxia, like previous experiments in Figures 2 and 4 . In 341 contrast, Foxg1 Cre/+ ; hACE2 fl/y mice survived without weight loss or hypoxia (Fig. 8j, k) . LSL-hACE2 mice were crossed to Foxg1 Cre/+ animals to generate Foxg1 Cre/+ ; LSL-hACE2 +/0 360 mice in which hACE2 is expressed exclusively in the OE and neuronal cells. Immunostaining 361 using anti-hACE2 or anti-pan-ACE2 antibodies revealed expression of hACE2 in the OE and 362 brain of Foxg1 Cre/+ ; LSL-hACE2 +/0 animals but not LSL-hACE2 +/0 littermates (Fig. 9b, c) , 363 consistent with Cre-dependent hACE2 expression. In contrast, hACE2 could not be detected in 364 the lung of either Foxg1 Cre/+ ;LSL-hACE2 +/0 or control LSL-hACE2 +/0 littermates (Fig. 9d) , 365 consistent with previously reported lineage tracing 38 . Exposure of Foxg1 Cre/+ ;LSL-hACE2 +/0 and 366 LSL-hACE2 +/0 mice to SARS-CoV-2 resulted in viral infection of the nasal OE and brain but not 367 the lung (Fig. 9e ,f and Ext. Data Fig. 10 ). Similar to findings in hACE2 fl/y and hACE2-GFP fl/y 368 mice, an immune cell infiltrate was observed adjacent to the choroid plexus and meninges of the 369 lateral ventricle 5 days after infection (Fig. 9g) . SARS-CoV-2 infection caused weight loss, 370 hypoxemia and death in Foxg1 Cre/+ ;LSL-hACE2 +/0 animals, with no evidence of illness in LSL-371 hACE2 +/0 littermates (Fig. 9h-j) . 372

Severe hypoxemia associated with lethal SARS-CoV-2 infection in Foxg1 Cre/+ ;LSL-373 hACE2 +/0 animals suggested that viral infection of the OE and brain might be sufficient to confer 374 pulmonary disease like that observed in hACE2 fl/y mice. Indeed, histologic analysis of the lungs 375 of infected Foxg1 Cre/+ ;LSL-hACE2 animals revealed lung epithelial inflammatory changes and 376 intravascular thrombosis similar to those seen in infected hACE2 fl/y mice ( Fig. 4 and Ext. Data 377 Fig. 4 ) despite the lack of lung infection (Ext. Data Fig. 10 ). These findings demonstrate that 378

confer severe COVID-19 associated with an acute lung injury/ARDS phenotype in mice-380 findings highly consistent with the loss of function studies described above (Fig. 8) . disease, why is SARS-CoV-2 virus detected in human brain samples by some but not all 435 investigators? We find that the virus moves rapidly from one tissue to another in a patchy 436 fashion, suggesting that there may be a narrow temporal and spatial window in which to detect 437 SARS-CoV-2 in a particular cell type. Examination of post-mortem brains from patients whose 438 disease course has been extended by aggressive treatment such as mechanical ventilation (e.g. 439 greater than 2 weeks 34 ) may bias towards analysis after virus is cleared. Human biopsies are also 440 limited in their sample size and may miss important sites of infection-an explanation for 441 negative findings supported by the fact that SARS-CoV-2 could not be detected in nasal 442 epithelium or brain in more than half of individuals examined by a recent negative study 51 . In 443 contrast, thorough examination of whole nasal cavity and brain from mice infected with a 444 measured amount of virus at a known timepoints during a highly reproducible disease course 445 enables detection of even transiently infected tissues. 446

2. Of immediate relevance is assessing the bioavailability and pharmacodynamics of current and 448 future therapies in the central nervous system. While design of drugs that overcome the blood 449 brain barrier is challenging, the ability of MMZ to protect against lethal, acute disease in hACE2 450 mice suggests that preventing infection in the OE may be an efficient and targeted means of 451 protecting against severe disease. Importantly, MMZ itself is likely not a viable treatment for 452 COVID-19 as it is an anti-thyroid medication and the high doses required to ablate olfactory 453 epithelium in rodents have not been studied in humans. Instead, vaccines aimed at stimulating 454 mucosal immunity or agents that interfere with SARS-CoV-2 binding to ACE2 at the OE 455 administered via a nasal spray may confer long or short-term protection without systemic side 456 effects. Such nasal prophylactics could be rapidly altered to protect against new viral variants 457 and be considered less dangerous or more acceptable to vaccine-hesitant individuals. 458

Interpretation of this study must consider several limitations. First, the mouse OE is more 459 developed compared to human OE; thus, a mouse model may bias toward disease mechanisms 460 involving the OE. In this regard, it is notable that we see complete lethality after exposure to 461 virus in hACE2 mice while most humans experience mild disease. This outcome may also 462 reflecs the administration of high viral titers that greatly exceed the inoculum received by most 463 human patients. Second, since mice are obligate nose-breathers, our studies utilize intranasal 464 SARS-CoV-2 administration. Unlike mice, humans are capable of mouth-breathing; thus, 465 transmission may be less dependent on the OE. However, anosmia is pathognomonic for human 466 disease and often precedes the onset of respiratory failure-a sequence consistent with that we 467 observed in hACE2 mice. Overall, our mouse models likely reflect the most severe disease 468 course experienced by human patients, e.g. those with the largest viral inocula and/or the greatest 469 number of preexisting conditions that act as disease risk factors. 470

Studies of human patients that more directly examine infection of the OE and brain early 471 in disease are challenging but will be required to fully validate and extend these findings. In The humanized ACE2 (hACE2) floxed and hACE2-GFP floxed alleles were generated 507 using CRISPR/Cas9 assisted mouse embryonic stem cell targeting as previously described 52 . A 508 gRNA sequence 5'-GGATGGGATCTTGGCGCACG-3' targeting intronic sequence 509 immediately prior to Exon 2 of Ace2 was cloned into the eSpCas9(1.1) plasmid (Addgene 510 71814). A targeting construct was designed to insert by homologous recombination the human 511 ACE2 cDNA followed by a floxed WPRE-SV40 polyA and FRT-ed neomycin resistance cassette 512 directly after the ATG-start codon of mouse Ace2 in exon 2. The human ACE2 cDNA sequence 513 was modified to utilize the mouse ACE2 signal peptide, codon optimized for mouse codon 514 usage, then further altered with silent mutations to remove cryptic RNA splice sites. The same 515 hACE2 targeting construct was utilized to generate the hACE2-GFP floxed targeting construct 516 except with the addition of a monomeric-Emerald GFP protein fused to the c-terminal sequence 517 of hACE2 through a GSG-flexible linker sequence. Both targeting constructs were synthesized 518 by Genscript. Properly targeted ES cell clones were confirmed using PCR screening of the 5' and 519 3' arms of homology and the entire targeted knock-in was PCR amplified for Sanger sequencing 520 prior to microinjection into V6.5 ES cells. Chimeras were mated to B6D2F1/J (Jackson 521 Laboratory, 100006) females to generate germline F1 mice. Genotyping primers that distinguish 522 zygosity against the 5' region of the knock-in are as follows: wildtype Forward 5'-523 ctcagtgcccaacccaagttc-3', wildtype Reverse 5'-atgtcttggcattttcctcggt-3', and mutant Reverse 5'-524

The Rosa26-LSL-hACE2 allele was also generated using CRISPR/Cas9 assisted mouse 526 embryonic stem cell targeting. A gRNA sequence 5'-cgtgatctgcaactccagtc-3' targeting the XbaI 527 restriction site conventionally used for Rosa26 targeted alleles was cloned into the eSpCas9(1. Infectious stocks were grown in Vero-E6 cells and stored at −80 °C. All work with infectious 561 virus was performed in a biosafety level 3 laboratory and approved by the Institutional Biosafety 562

Committee and Environmental Health and Safety. 563

Mice were anesthetized with isoflurane then intranasally infected with SARS-CoV-2 565 USA-WA1/2020 (BEI resources; NR-52281) by applying drops of pre-characterized viral stock 566 into the rostral meatus of the nose for a total volume of 50 µL per mouse. Mice were monitored 567 and weighed daily, then euthanized when they lost 20% of their starting weights as a predefined 568 humane endpoint. All mice studies were performed in a BSL-3 laboratory with accordance to 569 protocols approved by the Institutional Animal Care and Use Committee at Cornell University 570 (IACUC mouse protocol # 2017-0108 and BSL3 IBC # MUA-16371-1). 571

Vero E6 cells were seeded in 12 well plates with complete DMEM and incubated at 37°C 573 for 24 hours prior to infection. Lung tissue was homogenized in DMEM with 2% serum at 574 20ul/mg lung tissue. Supernatants were serially diluted and 100ul used to infect cells in 575 duplicates for 1hr at 37°C, gently mixed every 10 minutes, and overlayed with 1 ml of overlay 576 medium (DMEM with 4% serum and 0.3% oxoid agar). The cells were incubated at 37°C for 3 577 days, fixed with 4% PFA for 30 minutes, then stained with 200ul of 0.5% crystal violet in 30% 578 methanol for 15 minutes. Crystal violet was removed, the cells were washed three times with 1 579 ml water and plaques counted manually. 580

MouseStat Jr X (Kent Scientific) was used to measure heartrate and oxygen saturation 582 (SpO2) of mice prior to harvest. To acclimate the mice to recordings, the sensor was attached 583 daily during routine observation and weighing. Briefly, the sensor was applied to the rear leg and 584 data was recorded following readout stabilization defined as an unchanging recording over 5 585

To induce CreERT2 mediated recombination, animals at 8 weeks of age were gavaged 588 with 100 µL of a 30 mg/mL solution of tamoxifen/corn oil (Sigma Aldrich T5648). This was 589 done 3 consecutive days then animals were allowed to rest for 4 days before another three 590 consecutive daily doses (6 doses over 10 days). Animals were used for viral infection studies 2 591 weeks after completion of the tamoxifen dosing. 592

A 20 mg/mL solution of methimazole/sterile PBS (Sigma Aldrich M8506) was used to 594 administer a 100 mg/kg dose via intraperitoneal injection. Animals were inoculated with SARS-595

CoV-2 virus 24-28 hours after methimazole injection. 596

Mice were euthanized with ketamine/xylazine and underwent laparotomy and sternotomy 598 with subsequent left and right ventricular cardiac perfusion with 20 mL total of PBS. Trachea 599 was exposed and cannulated to allow for bilateral lung inflation. Lungs were gently inflated with 600 PBS infusion, which was stopped upon observation of terminal lung inflation to avoid over- The intact skull with skin/fur and eyes removed was fixed for a minimum of 72 hours and 608 removed from the animal BSL3 facility. The lower jaw was removed, and nasal cavity was 609 bisected in the sagittal orientation to preserve respiratory and olfactory epithelium. The nasal 610 cavity underwent de-calcification for 14 days in 0.5 M EDTA pH 8.0 at 4 degrees Celsius with 611 agitation prior to ethanol dehydration and paraffin embedding. The brain was removed from the 612 skull and dehydrated with ethanol for subsequent paraffin embedding and histology. 613

Lung tissue was homogenized in Trizol using a bead mill then stored at -80 degrees 615

Celsius. Whole blood was mixed with twice the volume of Trizol LS vortexed then stored at -80 616 degrees. RNA was extracted using chloroform phase separation and the RNeasy Mini Kit 617 Sections were then incubated with anti-NFH (chicken 1:5000, Aves Labs, NFH) and anti-KRT8 669 (rabbit 1:500, Sigma-Aldrich, SAB4501654) overnight at 4ºC, followed by incubation with 670 secondary antibodies. 671

ACE2 antibodies were validated for IHC and Western blotting using hACE2 del/y tissues. 673

Nucleocapsid and RNAscope detection of SARS-CoV-2 was performed simultaneously on 674 wildtype mouse tissue also infected with virus contemporaneously to experimental animals with 675 tissue sections on the same slide to ensure identical staining conditions. 676

Animals were inoculated with SARS-CoV-2 in blinded fashion without knowledge of 678 genotypes. At the time of harvest, hACE2 animals could not be handled in a blinded manner 679

given moribund appearance compared to wildtype. All animals were included in analyses except 680 those that spontaneously died prior to harvest where histology could no longer be obtained or 681 animals where the initial viral inoculation was observed to be inconsistent or concern for failure. 682

Unless specifically noted, all animals used in this study were male (ACE2 is X-linked) given the 683 excessive number of animals that would need to be generated to achieve homozygous females 684 with additional Cre-drivers. Foxg1 Cre ; LSL-hACE2 +/0 experiments in Figure 9 and 10 were done 685 with equal numbers of male and female mice. Prior determination of sample sizes could not be 686 performed given the completely unknown phenotype of our novel genetic models. Sample sizes 687

were pre-determined to be at least three animals per genotype, which was sufficient to achieve 688 statistical significance given the high reproducibility of our models and large effect size. NeoR, phosphoglycerate kinase promoter driven neomycin resistance cassette b, Immunoblotting 837 of whole tissue lysates from wild-type (WT) and hACE2 fl/y mouse tissues was performed using 838 an antibody recognizing both human and mouse ACE2 (panACE2). Total protein for each lane 839 was detected using Revert counterstain. Representative of 3 independent experiments, n = 3 840 animals per genotype. c, Immunoblotting of whole tissue lysates from wild type (WT), hACE2 fl/y 841 and hACE2 del/y tissues was performed using antibodies that specifically recognize human ACE2 842 genotype. f, Immunostaining using pan-ACE2 and human-ACE2 (hACE2) antibodies is shown 851 for wild-type and hACE2 fl/y small intestine co-stained with E-cadherin (enterocytes). Arrowheads 852 indicate ACE2+ enterocytes. n = 3 animals per genotype. g, Immunostaining using pan-ACE2 853 and human-ACE2 (hACE2) antibodies is shown for wild-type and hACE2 fl/y kidney co-stained 854 with E-cadherin (epithelium). Arrowheads indicate ACE2+ tubular epithelial cells. n = 3 animals 855 per genotype. Scale bars for all images, 50 µm. 856 CoV-2 virus. n= 11 (male) and 6 (female), one experiment. n.s p>0.05, *p<0.5, **p<0.01, 867 ***p<0.001, ****p<0.0001 by multiple unpaired two-tailed t-test or log rank Mantel Cox test. 868

Note: data for hACE2 fl/y infections at 10 5 and 10 4 titer are re-used throughout panels in this 869 

Immunohistochemistry of hACE2 fl/y and Sfptc CreERT2/+ ; hACE2 fl/y mouse lungs 6 days after 873 infection with 10 4 PFU of SARS-CoV-2 virus was performed using antibodies that recognize 874 SARS-CoV-2 nucleocapsid, DC-LAMP (alveolar type 2 cells) and PDPN (alveolar type 1 cells) 875 as well as the nuclear stain DAPI. N=4 for both genotypes, one experiment b, qPCR was 876 performed on hACE2 fl/y and Sfptc CreERT2/+ ; hACE2 fl/y mouse lungs harvested 6 days after infection 877 with 10 4 PFU of SARS-CoV-2 to measure total viral load. N=4 for both genotypes, one 878 experiment. c, Immunohistochemistry of hACE2 fl/y and Shh Cre/+ ; hACE2 fl/y mouse lungs 2 and 6 879 days after infection with 10 4 or 10 5 PFU of SARS-CoV-2 virus was performed using antibodies 880 that recognize SARS-CoV-2 nucleocapsid, DC-LAMP (alveolar type 2 cells) and PDPN 881 (alveolar type 1 cells) as well as the nuclear stain DAPI. N=6 for all genotypes, two independent 882 experiments. d, qPCR was performed on hACE2 fl/y and Shh Cre/+ ; hACE2 fl/y mouse lungs 883 harvested 2 and 6 days after infection with 10 4 or 10 5 PFU of SARS-CoV-2 to measure total viral 884 RNA load. Simultaneous measurement using whole blood was performed 6 days after infection 885 (shown in red) to measure circulating levels. e, Infectious viral load was measured by plaque 886 forming assay (PFU) from hACE2 fl/y and Shh Cre/+ ; hACE2 fl/y mouse lungs 6 days after infection 887 with 10 5 PFU of SARS-CoV-2. Scale bars, 50 µm. ***p<0.001; *p<0.05; ns p>0.05, significance 888 determined by unpaired two-tailed t-test. Immunohistochemistry of SARS-CoV-2 nucleocapsid and epithelial cell E-cadherin in the 908 respiratory epithelium, olfactory epithelium, and olfactory bulb 2 and 5-6 days after infection of 909 hACE2 fl/y and Shh Cre/+ ; hACE2 fl/y mice. Arrowheads indicate sites of viral nucleocapsid detection. 910

Representative of N=4 animals per genotype and timepoint. Scale bars 100 µm. c-d, 911

Immunohistochemistry of SARS-CoV-2 nucleocapsid, neuronal NeuN and glial cell GFAP in the Immunoblotting of whole brain lysates from human, wild-type mouse, hACE2 fl/y , and hACE2 del/y 942 animals with antibodies that recognize human and mouse ACE2 (pan-ACE2), or only human 943 ACE2 (hACE2). β-actin antibody concurrently used as a loading control. Representative of N=4 944

per genotype. f, Immunohistochemistry of ACE2 using pan-ACE2 or human-ACE2 specific 945 antibodies and neurons using NeuN or βIII-tubulin antibodies in wild-type and hACE2 fl/y mouse 946 Note: targeted allele is identical to hACE2 fl/y except for fusion of mEmerald to the c-terminus of 952 

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 700 Blocked by a Clinically Proven Protease Inhibitor

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and 703 ACE2

A molecular single-cell lung atlas of lethal COVID-19

Animal models for COVID-19

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. 709

COVID-19 treatments and pathogenesis including anosmia in K18-711 hACE2 mice

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human 713

Angiotensin-Converting Enzyme 2

Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory 716 system suggests mechanisms underlying COVID-19-associated anosmia

Nasal ciliated cells are primary targets for SARS-CoV-2 replication in 719 the early stage of COVID-19

COVID-19 and anosmia: A review based on up-721 to-date knowledge

Mild or Moderate Covid-19

A pneumonia outbreak associated with a new coronavirus of probable bat 726 origin

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis 728 in Covid-19

Inflammasome activation at the crux of severe 730 COVID-19

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Mouse model of SARS-CoV-2 reveals inflammatory role of type I 734 interferon signaling

ACE2 localizes to the respiratory cilia and is not increased by ACE 736 inhibitors or ARBs

Clinical course and risk factors for mortality of adult inpatients with 738 COVID-19 in Wuhan, China: a retrospective cohort study

Severe Covid-19

SARS-CoV-2 spike D614G change enhances replication and transmission

SARS-CoV-2 causes lung infection without severe disease in human 745 ACE2 knock-in mice

Sex differences in immune responses that underlie COVID-19 747 disease outcomes

Male sex identified by global COVID-19 meta-analysis as a risk factor 749 for death and ITU admission

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in 752

Progenitor identification and SARS-CoV-2 infection in human 755 distal lung organoids

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in 757 the Respiratory Tract

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 759 in the human respiratory tract

Evidence for an expansion-based temporal Shh gradient in specifying 762 vertebrate digit identities

The spatial landscape of lung pathology during COVID-19 764 progression

Clinical course and outcomes of critically ill patients with SARS-CoV-2 766 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

The use of alveolar epithelial type I cell-selective markers 769 to investigate lung injury and repair

COVID-19-related anosmia is associated with viral persistence and 772 inflammation in human olfactory epithelium and brain infection in hamsters

A cellular and spatial map of the choroid plexus across brain ventricles 775 and ages

Dysregulation of brain and choroid plexus cell types in severe COVID-777 19

Deep spatial profiling of human COVID-19 brains reveals 779 neuroinflammation with distinct microanatomical microglia-T-cell interactions

Olfactory transmucosal SARS-CoV-2 invasion as a port of central 782 nervous system entry in individuals with COVID-19

Olfactory toxicity 785 of methimazole: dose-response and structure-activity studies and characterization of 786 flavin-containing monooxygenase activity in the Long-Evans rat olfactory mucosa

Generation and analysis 789 of an improved Foxg1-IRES-Cre driver mouse line

Acute respiratory distress syndrome

Comparative pathogenesis of COVID-19, MERS, and SARS in a 794 nonhuman primate model

Respiratory disease in rhesus macaques inoculated with SARS-CoV-796 2

Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal 798 Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric 799 Symptoms

Brain imaging before and after COVID-19 in UK Biobank. medRxiv

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Neuroinvasion and Encephalitis Following Intranasal Inoculation of 805 SARS-CoV-2 in K18-hACE2 Mice

Severe acute 807 respiratory syndrome coronavirus infection causes neuronal death in the absence of 808 encephalitis in mice transgenic for human ACE2

Divergent and self-reactive immune responses in the CNS of COVID-19 811 patients with neurological symptoms

Assessment of Cognitive Function in Patients After

Cognitive deficits in people who have recovered from COVID-19

EClinicalMedicine 39, 101044

Assessment of the Frequency and Variety of 819 Persistent Symptoms Among Patients With COVID-19: A Systematic Review

Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks 822 the respiratory and olfactory mucosae but spares the olfactory bulb

Cerebral cavernous malformations are driven by ADAMTS5 825 proteolysis of versican

Efficient gene modulation in mouse 827 epiblast using a Sox2Cre transgenic mouse strain

A robust and high-throughput Cre reporting and characterization 830 system for the whole mouse brain

Immunoblotting of whole brain lysates from wild-type (WT), hACE2 fl/y , and

0001 by unpaired two-tailed t-test, one-way ANOVA with 993

Holm-Sidak correction for multiple comparisons, or log-rank Mantel Cox test

b-d, Immunohistochemistry of olfactory epithelium, cerebral 1000 cortex and lung from Foxg1 Cre/+ ;LSL-hACE2 +/0 and LSL-hACE2 +/0 mouse brain tissue was 1001 performed using antibodies that recognize human ACE2

Representative of N=2 per genotype

Immunohistochemistry of Foxg1 Cre/+ ;LSL-hACE2 +/0 and LSL-hACE2 +/0 mouse olfactory 1005

epithelium, olfactory bulb, and cerebral cortex 5-6 days after infection with 10 5 PFU of SARS-1006

CoV-2 virus using antibodies that recognize viral nucleocapsid, sustentacular cell E-cadherin, 1007 olfactory sensory neuron (OSN) βIII-tubulin, neuronal NeuN, or glial GFAP

OB-olfactory bulb. Asterisk indicates olfactory bulb with nucleocapsid staining

Arrows indicate nucleocapsid staining colocalized with βIII-tubulin+ OSNs (olfactory 1010 epithelium) or NeuN+ neurons (brain)

Weight loss and survival of LSL-hACE2 +/0 and Foxg1 Cre/+ ; LSL-hACE2 +/0 mice after infection 1013 with 10 5 or 10 4 PFU of SARS-CoV-2. Asterisks indicate timepoints at which significant 1014 differences in weight were observed between infected Foxg1 Cre/+

0001 determined by unpaired, two-tailed t-test 1016 or log-rank Mantel Cox test. i, Pulse oximetry of WT (LSL-hACE2

0001 determined by unpaired, two-tailed t-test

Extended Data Figure 1. Survival following SARS-CoV-2 infection of hACE2 fl/y mice in two 1022 facilities. a-b, Weight loss and survival of hACE2 fl/y mice were measured after infection with

SARS-CoV-2 virus at the Cornell or Penn animal biosafety level 3 (ABSL3) facilities. N=7 1024 (Cornell) and 14 (Penn) from 3 independent experiments. ***p<0.001 by unpaired two-tailed t-1025 test

Shh Cre is active in lower respiratory epithelium but spares the 1028 nasal cavity epithelium. a, Sites of Shh Cre activity in respiratory and gut epithelium are shown 1029 in red. RE (respiratory epithelium), OE (olfactory epithelium), OB (olfactory bulb

Lineage trace of Shh Cre activity in upper and lower respiratory epithelium using a Cre-activated, 1032 tdTomato allele (LSL-RFP)

Extended Data Figure 3. Reduced small intestine epithelial expression of hACE2 in Shh Cre

Immunohistochemistry of wild type, hACE2 fl/y and Shh Cre ; hACE2 fl/y small 1037 intestine using antibodies that recognize both human and mouse ACE2 (pan-ACE2) and only 1038 human ACE2 (hACE2) are shown

Extended Data Figure 4. Acute lung injury, hypoxemia and lethality in hACE2 fl/y and 1041

Shh Cre/+ ; hACE2 fl/y mice after infection with SARS-CoV-2. a-b, Weight loss and survival of 1042

hACE2 fl/y mice after infection with 10 5 PFU of SARS-CoV-2. N=8 1043 (hACE2 fl/y ) and 7 (Shh Cre/+ ; hACE2 fl/y ), two independent experiments. Note: data for hACE2 fl/y 1044 are the same as those shown in Figure 2d, e because Shh Cre/+ ; hACE2 fl/y animals were littermates 1045 of those animals. c, Pulse oximetry measured in wild-type (WT)

hACE2 fl/y mice at time of harvest 5-6 days after exposure to 10 5 PFU of SARS-CoV-2 virus

H&E) staining of wild-type (WT), hACE2 fl/y and Shh Cre/+ ; hACE2 fl/y lung 1048

tissue 6 days after exposure to 10 5 PFU of SARS-CoV-2 virus. Arrows, sites of broncho-vascular 1049 immune cell infiltrate. Asterisks, intravascular thrombus Representative of N=3 animals per 1050 genotype

Extended Data Figure 5. Extensive SARS-CoV-2 detection in hippocampus but minimal 1054 detection in neurons of the cerebellum and brainstem

Arrows indicate NeuN positive 1057 neurons with colocalized nucleocapsid staining. N=3 per genotype

Extended Data Figure 6. SARS-CoV-2 infection of the olfactory epithelium and olfactory 1062 bulb detected by in situ hybridization

Shh Cre/+ ; hACE2 fl/y mice infected with 10 5 viral titer was performed on 1064 tissue samples harvested 5-6 days post infection. Yellow arrows indicate positive hybridization 1065 signal in the olfactory bulb (OB), Red arrows indicate positive hybridization signal in the 1066 olfactory epithelium (OE). N=3 per genotype

Extended Data Figure 7. Expression of hACE2-GFP protein in hACE2-GFP fl/y kidney and 1070 small intestine. a, Immunoblotting of whole kidney lysate from wildtype, hACE2-GFP fl/y , and 1071 hACE2 fl/y animals using anti-GFP antibodies and antibodies specific for human-ACE2 (hACE2)

Revert TM total protein counterstain used for loading control. N=3 per genotype, two independent 1073 experiments. b, Immunohistochemistry of small intestine from wildtype and hACE2-GFP fl/X 1074 animals using antibodies that recognize GFP and E-cadherin (epithelium). N=3 per genotype, 1075 three independent experiments

Extended Data Figure 8. SARS-CoV-2 detection in neurons adjacent to the choroid plexus 1078 of hACE2-GFP fl/y mice. Immunohistochemistry of the choroid plexus along the lateral ventricle 1079 of wildtype and hACE2-GFP fl/y mice 6 days post-infection with 10 5 viral titer per mouse

Staining for viral nucleocapsid, neuronal NeuN, and glial GFAP. Arrows indicate nucleocapsid 1081 staining colocalized with NeuN

Results representative of N=3 per genotype. Scale bars 50 µm

Failure of methimazole to prevent lethal SARS-CoV-2 infection is 1085 associated with brain infection. a-b, Cerebral cortex (a) and lung (b) immunohistochemistry of 1086

The tissues shown on the far right ("hACE2 fl + MMZ 8 DPI") are from a hACE2 fl 1088 mouse that exhibited weight loss and required euthanasia 8 days following infection with

SARS-CoV-2 virus despite pre-treatment with MMZ. Cerebral cortex stained with viral 1090 nucleocapsid, neuronal NeuN and glial cell GFAP. Lung stained with viral nucleocapsid

alveolar type I cells PDPN, and alveolar type II cell DC-LAMP. Arrows indicate nucleocapsid 1092 staining colocalized with NeuN+ neurons or PDPN+ AT1 cells. N=4 per genotype except for 1093 N=1 (MMZ treated)

SARS-CoV-2 infection of OE and neurons is sufficient to confer 1096 pulmonary inflammation and intravascular thrombosis. a, Hematoxylin-eosin (H&E)

Foxg1 Cre/+ ; LSL-hACE2 +/0 lung tissue 6 days after exposure to 10 5 PFU 1098 of SARS-CoV-2 virus. Arrows, sites of focal consolidation

Scale bars 1100 100 µm. b, Immunohistochemistry of wild-type and Foxg1 Cre/+ ; LSL-hACE2 +/0 lung tissue 6 1101 days after exposure to 10 5 PFU of SARS-CoV-2 virus using antibodies against viral 1102 nucleocapsid, alveolar type 1 PDPN, and alveolar type II DC-LAMP. Representative of N=4 1103 animals per genotype

10 5 PFU of SARS-CoV-2 virus 1105 using antibodies against Intracellular adhesion marker-1 (ICAM-1) and Podoplanin (PDPN), or 1106 von Willebrand's Factor (vWF) and PECAM (endothelial cells). Arrowheads in d identify vWF-1107 positive microvasculature of the lung in Foxg1 Cre/+ ; LSL-hACE2 +/0 animals